8th Edition Conference

Partnership Opportunities in Drug Delivery

The Partnership Opportunities in Drug Delivery, organized by the The Conference Forum will take place from 17th October to 18th October 2018 in Boston, United States Of America. The conference will cover areas like strategic level program for pharma and biotech business development professionals on the latest drug delivery technologies available with ample networking opportunities.


  • Drug Deliverables
  • Business Development Opportunities
  • Partnering Opportunities


8:00 AM - 4:45 PM (General)

Entry Fees

* for details check official website


Delegates: 500 - 1000
Exhibitors: 10 - 50
* Estimated Count

Category & Type

Medical & Pharma


Frequency Annual
Next edition likely in Oct 2019
Past Editions October 19 - 20, 2017 (7th Edition)
October 27 - 28, 2016 (6th Edition)
October 05 - 06, 2015 (5th Edition)
October 14 - 15, 2014 (4th Edition)

Official Links

Website Contacts

Report Error
Claim this event

Event Reputation
Organizer Reputation
Based on 9 ratings
Venue Reputation
Based on 24 ratings


Logo Send Stall Book Request

The Conference Forum USA

21 events listed

Visitors Interested

Amy Asselta

Amy Asselta

Commercial Development Manger at Datwyler Pharma Packaging Middletown, United States
Jeffrey Carlisle

Jeffrey Carlisle

CEO at Pneuma Systems Corporation Portsmouth, United States
Bo Petersson

Bo Petersson

VP Business Development at Cambridge Consultants Cambridge, United Kingdom
Ann Daugherty

Ann Daugherty

Drug Delivery at Genentech, Inc. South San Francisco, United States
Marty Mason

Marty Mason

Senior Director at Artcraft Health Flemington, United States
robert schultheis

robert schultheis

President at zebrasci, inc. San Diego, United States
Wendy Naimark

Wendy Naimark

Vice President, R&D at Interface Biologics Toronto, Canada

Visitor Profile

Business Development Manager
Associate Director

Visitor Spread

Visitor Rating


Based on 8 Ratings

Visitor's Reviews

4 Amy Asselta Commercial Development Manger at Datwyler Pharma Packaging Edition Attended : Oct, 2018

Well managed. Initial confusion regarding breakout locations - resolved. Requested link for scheduling partnering meetings, delayed notification?

5 Ann Daugherty Drug Delivery at Genentech, Inc. Edition Attended : Oct, 2018

Provided insightful presentations and panels and outstanding partnering meetings.

5 Marty Mason Senior Director at Artcraft Health Edition Attended : Oct, 2018

Good show....great topics and partnership app

4 Jeffrey Carlisle CEO at Pneuma Systems Corporation Edition Attended : Oct, 2018

It was very well done- very effective

Speakers (past edition)

Abla Creasey

Abla Creasey

Senior Scientific Director at Janssen New York, United States
Vahe Bedian

Vahe Bedian

Director at AstraZeneca Pharmaceuticals Boston, United States
Lew Bender

Lew Bender

President & CEO at Intensity Therapeutics New York, United States
James Callaway

James Callaway

President & CEO at ArmaGen Technologies, Inc. San Diego, United States
PJ Anand

PJ Anand

Founder at Alcyone Lifesciences, Inc. Boston, United States
David Berry

David Berry

Partner at Flagship Ventures Boston, United States

Schedule & Agenda

Wed, 17 OctDay 1
Wed, 17 Oct 06:15 AM - 07:15 PMNetworking Reception & Partnering Meetings
Wed, 17 Oct 08:30 AM - 09:00 AMA Year in Review and PODD WelcomeIndustry year in review provided by Barbara Lueckel, PhDGlobal Business Development Director, Roche Partnering Innovation, Roche
Wed, 17 Oct 09:00 AM - 09:45 AMKeynote Fireside ChatDr Robert Langer and Amy Schulman, two dynamic entrepreneurs in biotech, will reveal their insights on drug delivery innovation and partnering in a fireside chat interview with Barbara Lueckel. Topics include:Case studies of drug delivery spin-outs from Dr Langer’s labThe path from lab to the clinic for a drug delivery biotechPositioning of drug delivery in the broad space of life science innovation
Wed, 17 Oct 09:45 AM - 10:15 AMStories from Bioinspiration to InnovationJeffrey Karp, PhDProfessor of Medicine, Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation, Brigham and Women’s Hospital. When developing technologies to solve medical problems, often one encounters significant hurdles, that at times seem insurmountable. Overcoming these hurdles requires new ways of thinking. One approach is to turn to nature for inspiration. Millions and millions of years of research and development at our fingertips, and all we need to do is look outside to the amazing creatures that inhabit our planet. This talk will explore medical technologies being developed that harness lessons from nature for inspiration. Some of the technologies that will be described are rapidly advancing to the clinic and some are already on the market helping patients.
Wed, 17 Oct 10:15 AM - 11:00 AMNetworking Break & Partnering Meetings, Exhibits OpenSponsored by Catalent
Wed, 17 Oct 11:00 AM - 11:45 AMPharma's Perspective on Partnering to Advance Drug Delivery Innovation in the R&D PipelineThis panel will include business development and technology assessment professionals actively involved in the scouting and evaluating of novel delivery technologies for such areas as oncology, ophthalmology, diabetes, and CNS. The audience will hear pharma’s general perspective on partnering, and will also gain insight into key strategic considerations in evaluating external drug delivery technologies vs. building internal capabilities.Moderator: Ronald L Smith, PhD Scientific AVP, Pharmaceutical Sciences, Merck Research Laboratories Panelists: James Cunningham, PhDExecutive Director, Drug Delivery, AllerganDan Groszmann, PhDPrincipal Engineer, Device Technologies Innovation Center, AmgenBarbara Lueckel, PhDGlobal Business Development Director, Roche Partnering Innovation, RocheImran Nasrullah, MS, JDDirector, Strategic Partnering, BD&L, Boehringer Ingelheim Pharmaceuticals Terry ReedDirector, Business Development, AstraZeneca
Wed, 17 Oct 11:45 AM - 12:45 PMHigh Volume Subcutaneous Drug Delivery: Challenges, Opportunities, and What the Future HoldsOver the past few years, there has been a dramatic increase in the number of therapeutic proteins delivered through intravenous infusion and subcutaneous delivery. Conversion of high volume intravenous infusion products to subcutaneous injection as well as optimization of subcutaneously delivered products can reduce treatment burden for patients, save provider time, and potentially reduce health care costs.Leading biopharmaceutical thought leaders will outline the challenges, opportunities, and emerging trends associated with high volume subcutaneous delivery. The panel participants will discuss the technical considerations, development approaches, and commercial implications.
Wed, 17 Oct 12:45 PM - 02:00 PMLunch & Partnering Meetings
Wed, 17 Oct 02:00 PM - 02:15 PMA Year in Review on the Drug Delivery PipelinePharmaCircle will present a brief overview of drug delivery pipeline and then highlight and examine innovative and potentially impactful drug delivery based clinical stage pipeline with both formulation and device based technologies.
Wed, 17 Oct 02:14 PM - 04:15 PMTrack 1A: Injectable Formulation & Device TechnologiesCompanies will present technologies to improve the formulation and delivery of injectable drugs. Examples of technologies presented: sustained release microspheres, nanoparticles, enabling formulation system for high volume drugs, novel injectors, pre-filled syringes, and multi-vial/multi-syringe systems.
Wed, 17 Oct 02:15 PM - 06:15 PMDrug Delivery Technology Presentations, six sessionsAttendees can choose between the following sessions: Drug Delivery Devices, Injectable Technologies and Non-Injectable Technologies (oral, transdermal, transmucosal and ophthalmic). In these tracks, a wide range of delivery technologies will be presented such as wearable patch pumps, subcutaneous formulation enhancing technologies, sustained release delivery systems, nanoparticle technologies, novel auto-injector devices, “connected” drug delivery systems (digital devices), bioavailability enhancing technologies, long-acting ocular implants, microneedle patches, and orally-disintegrating dosage forms.
Wed, 17 Oct 02:15 PM - 04:15 PMTrack 2A: Non-Injectable Technologies: OralCompanies will present controlled release, modified-release, colon-targeted, and orally-disintegrating delivery systems, as well as bioavailability & solubility enhancing technologies.
Wed, 17 Oct 02:15 PM - 04:15 PMTrack 3A: Device TechnologiesCompanies will present a wide range of novel delivery devices such as needle-free delivery devices, auto injectors, patch pumps/wearable delivery systems, and similar devices. This session also includes “connected” devices and digital health technologies.
Wed, 17 Oct 04:15 PM - 06:15 PMTrack 1B: Injectable Formulation & Device TechnologiesCompanies will present technologies to improve the formulation and delivery of injectable drugs. Examples of technologies presented: sustained release microspheres, nanoparticles, enabling formulation system for high volume drugs, novel injectors, pre-filled syringes, and multi-vial/multi-syringe systems.
Wed, 17 Oct 04:15 PM - 06:15 PMTrack 2B: Non-Injectable Technologies: Oral, Mucosal, Transdermal, Ophthalmic and PulmonaryCompanies will present a wide range of technologies for oral, mucosal, buccal, ophthalmic, transdermal, vaginal, and pulmonary delivery. Examples of technologies presented: polymeric delivery systems, dermal nanoparticle systems, and next-generation inhalers.
Wed, 17 Oct 04:15 PM - 06:15 PMTrack 3B: Device TechnologiesCompanies will present a wide range of novel delivery devices such as needle-free delivery devices, auto injectors, patch pumps/wearable delivery systems, and similar devices. This session also includes “connected” devices and digital health technologies.
Thu, 18 OctDay 2
Thu, 18 Oct 08:00 AM - 08:30 AMBreakfast in Exhibit Hall and Partnering Meetings
Thu, 18 Oct 08:30 AM - 08:40 AMChair’s WelcomeChair's Welcome from Barbara Lueckel, PhDGlobal Business Development Director, Roche Partnering Innovation, Roche
Thu, 18 Oct 08:40 AM - 09:10 AMIndustry Keynote: Harnessing the Digital Exhaust: Incorporating Wellness into the Pharma Model and How Drug Delivery will be a Key EnablerThe pharmaceutical sector remains one of the largest components of the US and global economy with sales exceeding $450B domestically and $900B worldwide. Historically the industry has relied on the ‘blockbuster’ model for drug entry, where drugs with >$1B+ annual sales allow investments to be made in early stage projects and smaller markets. However, the industry is undergoing a pivotal transformation as traditional drugs are supplanted by next generation product systems where, in some cases, the drug is only a component of the overall product offering. This situation has created a compelling entry point for non-traditional competitors and start-ups to access this market and potentially re-define the value model associated with drug pricing.And while, for more than a decade, the pharmaceutical industry has been caught up discussing its role in “beyond the pill” solutions, it will now need to realize a rapid evolution of its current business model in order to remain competitive. The opportunity to reimagine this and move from a reactive to prevention model, and in many cases a fully “closed loop” solution, has finally arrived. At the core of such an evolved model will certainly be a dynamic patient interface which leads to extraordinary patient engagement. And with the delivery system being one of the most intimate parts of this interface, there is no question they will serve as a key enabler going forward. As evidenced by a number of franchises over the past 20 years, a great delivery system can be a true differentiator or can it be a debilitating handicap.A review of the current and future state along with perspective and case studies will be provided in order to help shed light on the areas of needed focus and corresponding opportunity.
Thu, 18 Oct 09:10 AM - 09:35 AMThe Pediatric Patient PerspectiveModerated by:Cornell Stamoran, PhDVP of Corporate Strategy and Government Affairs, Catalent Pharma SolutionswithAlex RinaudoPatient AdvocateValerie BowlingPatient Advocate
Thu, 18 Oct 09:35 AM - 10:15 AMDigital Health: Paradox or Paragon?In today’s digital world, we are seeing self-driving cars taking the first leap, while Amazon’s Alexa, Google Assistant and Apple’s Siri are becoming commonplace in our households. We are also experiencing increased adoption of digital or “smart” technology to improve healthcare. On one side, we view the “smart” ecosystem and connected medical devices as a way to improve patient adherence and help healthcare providers make evidence-based personalized care decisions; but on the other hand there is the debate about the value, return on investment, etc. for digital health.This panel discussion not only touches on the strategic topic of digital health but also dives deeper into more pragmatic approaches to execution, value propositions, etc. Our panel consists of bio-pharma executives and strategic partners who are not only KOLs but also possess a successful track record of implementing digital health solutions in the field. The panel will also help to shed light on current digital health strategies currently employed while providing “food for thought” for organizations interested in adopting new digital technology but still looking for the right value proposition. Moderator:Dhairya MehtaDirector, eHealth & Connectivity, Medical Device & Combination Products, ShirePanelists:Supriya Lagu, PhDDirector, Digital Health Technology, BiogenKal PatelKal Patel, MDSVP of Digital Health, FlexPaul UphamPaul UphamSenior Principal, Smart Device Technology Center, Roche/GenentechNeil WilliamsDirector Front-End Innovation – Head of Connected Health, Medicom Innovation Partner Ltd, a Phillips-Medisize Company
Thu, 18 Oct 10:15 AM - 11:00 AMNetworking Break in Exhibit Hall and Partnering Meetings
Thu, 18 Oct 11:00 AM - 11:30 AMMaximizing the Value of Collaboration for Novel Device DesignPartnering is a vital aspect of medical device development; it provides necessary resources and expertise for development, and brings in new viewpoints and experiences, which truly drive product innovation. This type of collaboration, however, also adds a layer of complexity to a development project that must be carefully managed to successfully reach the end goal. In this session, the speakers will present challenges, best practices and lessons learned for partnering, using case studies for illustration. The speakers will highlight ways they maximized the value of collaboration from the outset, including: how they identified and moved forward with the “right” partner; built a productive multi-partner team; productively managed communications and expectations throughout the development cycle; measured performance; and made critical decisions to reach a successful outcome.Doug Boyd, PE, PMPManager, Medical Devices and Health Analytics, BattelleGary HennigerSenior Director Global Device R&D Operations, Teva
Thu, 18 Oct 11:30 AM - 12:30 PM8th Annual Company SpotlightsIn this session, we highlight four companies to discuss their partnering philosophy, current needs and scouting interests, as related to drug delivery.Advait BadkarAdvait Badkar, PhDSenior Director, Novel Delivery Technologies, BioTherapeutics, PfizerGrégoire Schwach, PhDHead of Drug Delivery, F. Hoffmann-La Roche LtdSrini Sridharan, PhDHead, Materials Science & Engineering, Bristol-Myers SquibbSimon ToddScience and Innovation Lead, AstraZeneca
Thu, 18 Oct 12:30 PM - 01:30 PMLuncheon Roundtables & Partnering MeetingsThe PODD Luncheon Roundtables are open to all delegates and feature a dedicated moderator for each topic. Participating in a Roundtable session is an excellent way to engage in in-depth discussions and meet colleagues with similar interests. Be sure to pick up your Grab-and-Go lunch and join the conversation.Sponsored by:Long-acting Ocular Drug Delivery Technologies: Challenges and Opportunities Led by:Viral Kansara, PhDHead of Pharmacology and Drug Discovery Lab, Global Project Team Leader, Ophthalmology, Novartis
Thu, 18 Oct 01:30 PM - 02:10 PMDDS Technology Soapbox@PODDSponsored by:PfizerThis session features five minute talks on cutting-edge technologies, inventions and ideas. The PODD Soapbox section is open to start-up entrepreneurs, inventors, licensing officers and university researchers.Moderator:Patrick Lim Soo, PhDSenior Principal Scientist, Novel Delivery Technologies, PfizerPresenting Companies:Cam Med LLCCinti MedicalConsegna PharmaWyss InstituteBetter SenseMassachusetts General HospitalSiNON Therapeutics
Thu, 18 Oct 02:10 PM - 02:40 PMDisruptive New Models for Advancing Drug Delivery InnovationsThis panel will discuss the 2028 model of commercialization – new game-changing models of commercialization that accelerate the development and commercialization of early stage drug delivery technologies.Moderator:Rosemarie TrumanFounder and CEO, The Center for Advancing InnovationPanelists:Eric Elenko, PhDChief of Research and Strategy, PureTech HealthKristen KosofskyKristen C KosofskySenior Managing Director, Life Sciences, Hercules CapitalScott PappasScott E Weiner, MBAPartner, Pappas Capital
Thu, 18 Oct 02:40 PM - 03:20 PMDelivering mRNA Drugs and Vaccines: Progress and Future OutlookmRNA vaccines represent a promising alternative to conventional vaccine approaches for infectious diseases as well as oncology indications, including an emerging application for personalized cancer vaccines. As a technology, mRNA has the potential to enable more rapid design and optimization of antigens, improve quality of immune response due to in situ antigen production, permit expression of multiple antigens, and support more rapid and versatile development and manufacturing platforms.This panel will discuss current state of mRNA vaccines research and opportunities related to:mRNA design optimization for improved stability and antigen translationnext-generation delivery approaches for mRNA vaccinesmRNA drug substance and drug product CMCsafety and regulatory considerationsModerator:marian gindyMarian Gindy, PhDExecutive Director, Discovery Pharmaceutical Sciences, MerckPanelists:Orn AlmarssononÖrn Almarsson, PhDHead of Formulations, Moderna TherapeuticsDanilo Casimiro, PhDVP & Head, External R&D and Vaccine Platforms, SanofiSybil Williams, PhDSenior Principal Scientist, Personalized Cancer Vaccines Biology Lead, Merck
Thu, 18 Oct 03:20 PM - 04:00 PMInnovations and Advances in Protein and Peptide Drug DeliveryThis panel will discuss the latest strategies for improving the delivery of protein and peptide drugs, including methods and technologies to improve stability and half-life, as well as administration to the patient. Panelists will also review progress and challenges related to non-invasive delivery, including oral administration.Moderator:Joël Richard, PhDHead of Technical and Pharmaceutical Operations, MedinCellPanelists:Mark CurrieMark Currie, PhDSVP, Chief Scientific Officer, and President of R&D, Ironwood PharmaceuticalsMohamed E H ElSayed, PhDSr. Research Advisor, BioTDR Formulation/Delivery, Eli Lilly and CompanyAdam Mezo, PhDSr. Director, Head of Molecular Design, Ferring Research Institute, IncDouglas P Nesta, PhDSenior Director, Biopharmaceutical Product Sciences, GSKJulia Rashba-Step, PhDVP, Research & Development and Alliance Management, Phosphorex
Thu, 18 Oct 04:00 PM - 04:20 PMThe Role of Digital Biomarkers in the Future of Drug Delivery
+ show more

Visitor Ticket Price

2195 USD Standard Final Early Bird
1097.5 USD Academic / Non-profit / Govt. Final Early Bird
42.348458 -71.077396

Venue Map & Directions

map of The Westin Copley Place, Boston

The Westin Copley Place, Boston

10 Huntington Ave, Boston, MA 02116

Get Directions

Featured Hotels in Boston

More Hotels